Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival

Expression of tyrosine kinases may limit effectiveness of agents against sarcomas

2012-05-02

(Press-News.org) To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.

Sarcomas are relatively rare forms of cancer. In contrast to carcinomas, which arise from epithelial cells (in breast, colon and lung cancers, for example), sarcomas are tumors derived from bone, fat, muscle or vascular tissues.

"Sarcomas are rare, diverse malignancies that arise from connective tissues," said study lead author Eric B. Haura, M.D., program leader for Experimental Therapeutics. "We hypothesized that we could identify important proteins that drive the growth and survival of these poorly understood sarcomas using an approach to characterize signaling proteins using mass spectrometry."

According to Haura, whose lab focuses on signaling pathways in cancer and understanding the role of kinases, protein phosphorylation plays a significant role in a wide range of cellular processes and is commonly disrupted in diseases such as cancer. The study approach is novel by engaging proteomics, an emerging and increasingly powerful approach to study proteins in disease in a more global and unbiased manner.

In this study, the Moffitt researchers identified 1,936 unique tyrosine phosphorylated peptides corresponding to 844 unique phospho-tyrosine proteins and found 39 tyrosine kinases in sarcoma cells. Of the 99 tyrosine kinases present in the human genome, the research team identified peptides corresponding to nearly 40 percent of the tyrosine kinome.

"Tyrosine kinases play an important role in controlling the hallmarks of cancer, and they have a proven track record as druggable targets for cancer treatment. Our goal was to produce a 'landscape' of tyrosine phosphorylated proteins and tyrosine kinases prioritized for subsequent functional validation," Haura said. "In our study, we identified numerous tyrosine kinases that can be important for cellular signaling in human sarcomas that could drive the natural progression of sarcoma and, therefore, could be targeted by small molecule inhibitors aimed at altering sarcoma progression."

Questions remain, however, about which, if any, of the 40 tyrosine kinases the researchers identified in sarcoma tumor cell lines act to regulate sarcoma tumor cell growth and tumor survival.

"The answers to this question can help prioritize which potential targets to examine further, including advancement into trials of patients with advanced sarcoma," explained Haura. "As a first step, we screened sarcoma cell lines against a number of inhibitors selected, all based on the tyrosine kinases we identified, and identified some active drugs."

While the researchers found kinases in sarcoma cells that deserved further study, they also concluded that the sarcoma cells tested expressed multiple tyrosine kinases. That great number may limit the effectiveness of targeted agents.

"We think this approach could hold promise in profiling tumors directly from patients and can complement existing genetic data on sarcomas. Our results show this is feasible in tumor tissues, and we hope to advance this further by directly studying additional tumors from sarcoma patients."

### Their study appeared in a recent issue of Cancer Research published by the American Association for Cancer Research.

About Moffitt Cancer Center Follow Moffitt on Facebook: www.facebook.com/MoffittCancerCenter
Follow Moffitt on Twitter: @MoffittNews
Follow Moffitt on YouTube: MoffittNews

Located in Tampa, Moffitt Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center, which recognizes Moffitt's excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt is also a member of the National Comprehensive Cancer Network, a prestigious alliance of the country's leading cancer centers, and is listed in U.S. News & World Report as one of "America's Best Hospitals" for cancer.

ELSE PRESS RELEASES FROM THIS DATE:

Sirma Mobile Inc. Announces Release of New App That Allows Businesses to Effectively Manage Staff Attendance

2012-05-02

Sirma Mobile, Inc. today announced the release of mTimeCard, a free mobile app for both iPhone and Android that lets SMBs easily monitor their employees' timekeeping and attendance. "It is not only staff administration, but managing most of a company's marketing activities, checking inventory or dealing with suppliers, for example. A simple time-and-effort-saving solution will be highly appreciated," said business owners interviewed during the pilot tests. To make it easier for vendors to monitor attendance, Sirma Mobile has developed a mobile application ...

Anti-HIV drug use during pregnancy does not affect infant size, birth weight

2012-05-02

Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study. However, at 1 year of age, children born to the tenofovir-treated mothers were slightly shorter and had slightly smaller head circumference—about 1 centimeter each, on average—than were infants whose mothers did not take tenofovir. ...

Researchers gain better understanding of mechanism behind tau spreading in the brain

2012-05-02

Researchers at Mount Sinai School of Medicine have gained insight into the mechanism by which a pathological brain protein called tau contributes to the progression of Alzheimer's disease (AD) and other neurodegenerative disorders. This finding, published in the most recent issue of the Journal of Biological Chemistry, may provide the basis for future investigations on how to prevent tau from damaging brain circuits involved in cognitive function. Previous studies have shown that the abnormal folding, or misfolding, and buildup of tau are key neuropathological features ...

Low-dose whole-body CT finds disease missed on standard imaging for patients with multiple myeloma

2012-05-02

Low dose whole body CT is nearly four times better than radiographic skeletal survey, the standard of care in the U.S., for determining the extent of disease in patients with multiple myeloma, a new study shows. The study, conducted at the University of Maryland in Baltimore, included 51 patients who had both a radiographic skeletal survey as well as a low dose whole body CT examination. The total number of lesions detected in these patients with low dose whole body CT was 968 versus 248 detected by radiographic skeletal survey, said Kelechi Princewill, MD, the lead author ...

Michaels Inspires Dads With Easy Ideas for Handmade Mother's Day Gifts

2012-05-02

Dad may be better with a hammer than a glue gun, but Michaels makes it easy for dads to help their children create special Mother's Day gifts for Mom. With hundreds of DIY gift ideas online and low-cost in-store gift-making events from Michaels, dads and their children will have fun creating a memorable handmade gift. Dads with an artistic flair can help their children create personalized handmade cards, while dads and kids with green thumbs can embellish garden stepping stones. From decorated mugs to custom designed apparel to festive cupcakes, Michaels features quick ...

Cone beam CT proves better for visualizing some causes of hearing loss at half the radiation dose

2012-05-02

Cone beam CT is superior to mutidetector CT for detecting superior semicircular canal dehiscence or the so called third window (a small hole in the bony wall of the inner ear bone that can cause dizziness and hearing loss) and it uses half the radiation dose, a new study shows. The study, conducted in Bruges, Belgium, included 21 patients who had both a cone beam CT and a multidetector CT examination of their right and left temporal bones, said David Volders, MD, one of the authors of the study. Two radiologists reviewed the images from both exams and scored them based ...

Soft & Shield Hand Sanitizer and Moisturizer, a Safe and Healthy Alternative to Alcohol Based Hand Sanitizers

2012-05-02

The current news and publicity of teenagers consuming alcohol based hand sanitizers in an effort to get intoxicated has alarmed parents. In addition, there have been recent reports of many cases of alcohol poisoning by children under 5 from ingesting alcohol hand sanitizers. We believe consumers are seeking a superior and safer product for their families to use. Many public health officials are becoming worried that these types of incidents could be evidence of a dangerous and serious new fad. With these alarming new reports, we believe concerned parents need a safer ...

JCI early table of contents for April 30, 2012

2012-05-01

ONCOLOGY Lymphoma therapy could deliver a double punch | Back to top B cell lymphomas are a group of cancers of that originate in lymphoid tissue from B cells, the specialized immune cell type that produces antibodies. The development of B cell lymphoma is associated with several known genetic changes, including increased expression of MYC, a transcription factor that promotes cell growth and division. In this issue of the JCI, Andrei Thomas-Tikhonenko and his colleagues at the University of Pennsylvania in Philadelphia report on their studies to better understand the ...

UC Davis researchers create molecule that blocks pathway leading to Alzheimer's disease

2012-05-01

UC Davis researchers have found novel compounds that disrupt the formation of amyloid, the clumps of protein in the brains of people with Alzheimer's disease believed to be important in causing the disease's characteristic mental decline. The so-called "spin-labeled fluorene compounds" are an important new target for researchers and physicians focused on diagnosing, treating and studying the disease. The study, published today in the online journal PLoS ONE, is entitled "The influence of spin-labeled fluorene compounds on the assembly and toxicity of the Aβ peptide." "We ...

Key lessons from history on alcohol taxes

2012-05-01

Steep rises in taxes on alcohol do not necessarily reduce consumption, according to research funded by the Economic and Social Research Council (ESRC) into the history of intoxicants in 16th and 17th England. Dr Philip Withington at the University of Cambridge has found that affluence rather than poverty has tended to drive consumption levels, especially among the middle classes and higher,even though legislation and enforcement is often focused on the poorer parts of the population. "If alcohol consumption is traditionally an index of affluence, then minimum pricing ...

Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: